ABC |
abciximab |
AC |
anticoagulant drugs |
ACE |
acenocoumarol |
ACL |
combination of acetylsalicylic acid and clopidogrel |
ADRs |
adverse reactions |
AF |
atrial fibrillation |
API |
apixaban |
ARG |
argatroban |
BEM |
bemiparin |
BIV |
bivalirudin |
CER |
certoparin |
CI |
confidence interval |
CIL |
cilostazol |
CLO |
clopidogrel |
DAB |
dabigatran |
DAL |
dalteparin |
DAN |
danaparoid |
DAS |
combination of dipyridamole and acetylsalicylic acid |
DIP |
dipyridamole |
DOACs |
direct oral anticoagulant drugs |
EDO |
edoxaban |
EEA |
European Economic Area |
EMA |
European Medicines Agency |
ENO |
enoxaparin |
EPT |
eptifibatide |
EV |
EudraVigilance |
FLU |
fluindione |
FON |
fondaparinux |
HEP |
unfractionated heparin |
ICSR |
Individual Case Safety Report |
LEP |
lepirudin |
LMWHs |
low molecular weight heparins |
ME |
medication errors |
MedDRA |
Medical Dictionary for Regulatory Activities |
NAD |
nadroparin |
NR/NS |
not recovered/not resolved |
PRA |
prasugrel |
PT |
preferred term |
RIV |
rivaroxaban |
ROR |
reporting odds ratio |
SOC |
system organ classes |
TCL |
ticagrelor |
TIC |
ticlopidine |
TIN |
tinzaparin |
TIR |
tirofiban |
VKAs |
vitamin K antagonists |
WAR |
warfarin |